Radiance Biopharma has filed a notice of an exempt offering of securities to raise $30,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Radiance Biopharma is raising up to $30,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Robert Brooks played a…